Cite
HARVARD Citation
Berenbaum, F. et al. (n.d.). LB0007 SUBCUTANEOUS TANEZUMAB FOR OSTEOARTHRITIS PAIN: A 24-WEEK PHASE 3 STUDY WITH A 24-WEEK FOLLOW UP. Annals of the rheumatic diseases. pp. 262-264. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Berenbaum, F. et al. (n.d.). LB0007 SUBCUTANEOUS TANEZUMAB FOR OSTEOARTHRITIS PAIN: A 24-WEEK PHASE 3 STUDY WITH A 24-WEEK FOLLOW UP. Annals of the rheumatic diseases. pp. 262-264. [Online].